Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, William M Drake et al.|New England Journal of Medicine|2000Cited by 874
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistAart Jan van der Lely, Michael O. Thorner, R. Kent Hutson et al.|The Lancet|2001Cited by 643
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An UpdateAndrea Giustina, Шломо Мелмед, Marcello D. Bronstein et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 363
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparationsJens Sandahl Christiansen, Kevin C.J. Yuen, Philippe Backeljauw et al.|European Journal of Endocrinology|2016Cited by 144